As lights around the world glow red today, Fred Hutch-based researchers lead global effort to end the pandemic
Dec. 1, 2017
| By Mary Engel / Fred Hutch News Service
The HIV Vaccine Trials Network is having a banner year. Last month in South Africa, the network launched a clinical trial called the Imbokodo Study to test an experimental vaccine regimen designed to protect against HIV subtypes around the world. Over the coming months, the Imbokodo study will roll out in four other southern African countries.
We now know that microbial communities, especially in our guts, profoundly affect immune response
Nov. 22, 2017
| By Sabin Russell / Fred Hutch News Service
Scientists at Fred Hutch are studying how the microbiome alters the immune system’s response to vaccines. Their work is already providing new insights on interactions between microbes in the body and the immune system that have implications for improving many types of vaccines.
Studies of how the virus evolved and how it might change down the road could help researchers develop vaccines or cures for the infection
Nov. 20, 2017
| By Rachel Tompa / Fred Hutch News Service
At approximately 100 years old, HIV is a relatively recent arrival on the human virus scene. But its roots stretch back much farther. Understanding where the virus has come from can help us understand where it’s going — and how to stop it — say evolutionary biologists.